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Abstract
Background: Current small animal models for studying HIV-1 infection are very limited, and this
continues to be a major obstacle for studying HIV-1 infection and pathogenesis, as well as for the
urgent development and evaluation of effective anti-HIV-1 therapies and vaccines. Previously, it was
shown that HIV-1 can infect cotton rats as indicated by development of antibodies against all major
proteins of the virus, the detection of viral cDNA in spleen and brain of challenged animals, the
transmission of infectious virus, albeit with low efficiency, from animal to animal by blood, and an
additional increase in the mortality in the infected groups.
Results: Using in vitro experiments, we now show that cotton rat cell lines engineered to express
human receptor complexes for HIV-1 (hCD4 along with hCXCR4 or hCCR5) support virus entry,
viral cDNA integration, and the production of infectious virus.
Conclusion:  These results further suggest that the development of transgenic cotton rats
expressing human HIV-1 receptors may prove to be useful small animal model for HIV infection.
Background
All vaccines and therapeutic strategies against HIV-1 must
be evaluated in animal models in order to select those that
may be appropriate to further advance into clinical trials
in humans. It is the goal of such animal models to recreate
critical aspects of viral replication, transmission and
pathogenesis as seen in humans. The most utilized animal
models for developing anti-HIV-1 vaccines and drugs
have been the non-human primate (NHP) systems[1].
NHPs do not efficiently replicate HIV-1 due to host restric-
tion factors[2,3]. Thus, current NHP models are based on
infection of different species of macaques, or less often
chimpanzees, with lentiviruses of non-human primates,
i.e. simian immunodeficiency viruses (SIVs), or with chi-
meric viruses, i.e. simian-human immunodeficiency
viruses (SHIVs). Although substantial knowledge has
been gained from modeling HIV-1 infection in NHP, the
high expenses, the ethical concerns associated with per-
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forming experiments in primates, and their outbred
nature continue to represent important obstacles to accel-
erate the development of new vaccines and therapies.
Since small laboratory animals are unable to replicate
HIV-1 due to a series of species-specific blockages includ-
ing entrance and viral gene transcription[4], intensive
efforts were directed to modify these models to render
them permissive for HIV-1 infection. Hence, humanized
mouse models, namely severe combined immunodefi-
ciency (SCID) mice in which human peripheral blood
mononuclear cells are injected peritoneally (hu-PBL-
SCID), or in which surgical engraftment of human fetal
hematopoietic tissue, namely thymus and liver, is
implanted under the kidney capsule (hu-Thy/Li-SCID),
have been used to achieve productive HIV-1 infec-
tion[5,6]. However, these are technically very challenging
studies, are time consuming, and do not fully recapitulate
HIV-1 infection within the context of an intact immune
system.
Binding of HIV-1 envelope (Env) to both CD4 and an
appropriate member of the seven-transmembrane G-pro-
tein-coupled receptor superfamily are necessary for the
efficient entry of HIV-1[7,8]. Several different chemokine
receptors (CCR2b, CCR3, CCR5, or CXCR4) or orphan
chemokine receptor-like molecules (STRL33, GPR1,
GPR15, V28, APJ) may participate in HIV-1 entry, but
hCXCR4 and hCCR5 are the principal co-receptors for X4
(T-cell line-tropic) or R5 (macrophage-tropic) isolates,
respectively. Blocking and down-regulation of these two
chemokine receptors are ways by which their physiologi-
cal ligands or modified analogues can prevent or reduce
HIV-1 entry[9].
The characterization of HIV-1 receptors prompted the
development of several transgenic animals expressing the
human receptors for HIV-1, including mice[10,11],
rats[12], and rabbits[13,14]. The outbred transgenic rat
model, expressing hCD4 and CCR5 on lymphocytes, mac-
rophages, and microglia, have been recently shown to be
promising for testing antiviral compounds targeting HIV-
1 entry and reverse transcription, despite the transient lev-
els of HIV-1 replication[15]. These results are encouraging
for the anti-HIV-1 drug development field and further val-
idate the transgenic approach to develop small animal
models for HIV-1 research.
Previously, we and others [16-19] have shown evidence of
HIV-1 infection in two cotton rat species (Sigmodon
hispidus and S. fulviventer). In one study [16] cotton rats
inoculated with HIV-1 developed detectable amounts of
proviral DNA in peripheral blood mononuclear cells
(PBMC). Virus inoculation induced a distinct and charac-
teristic HIV-1 antibody response that in some animals
included the elicitation of antibodies that recognized all
the major HIV-1 antigens, and that persisted for at least 52
weeks post-infection.
In another series of studies, Rytik and collaborators [17-
19] infected cotton rats (S. hispidus) with a Russian isolate
of HIV-1. Analysis of the infected animals showed that
75% of the samples from spleen and half of the samples
from brain obtained 3 months post-infection contained
proviral DNA, whereas all the samples from both tissues
obtained 6 months post-infection were positive for provi-
ral DNA. Taken together, these results suggest that low lev-
els of productive infection may occur in cotton rats.
We hypothesized that the lack of specific HIV-1 receptors
on the surface of cotton rat cells strongly reduces viral
entry, and although additional intracellular obstructions
may exist, entry appears to be the major feature responsi-
ble for the restricted viral replication seen in vivo. In this
new set of experiments we demonstrate that primary cot-
ton rat macrophages, transfected with a HIV-1 backbone
plasmid encoding a luciferase reporter gene, are able to
support HIV-1 gene expression. Furthermore, by produc-
ing a series of cotton rat cell lines expressing human CD4
and CXCR4 or CCR5, we were able to demonstrate that
CD4 and co-receptor expression was sufficient to enhance
HIV-1 entry, DNA integration, and production of infec-
tious viral particles in cotton rat cells.
Results
Isolation of cotton rat cells expressing human CD4 and 
HIV-1 co-receptors
To demonstrate that cotton rat cells lack the strong tran-
scriptional blockages for HIV-1 replication that other
rodents have and that virus entry is the major hurdle for
HIV-1 to replicate in this species, clones of the cotton rat
cell lines VCRT (C17) and CCRT (C4, C5, and C6)
expressing hCD4 and hCCR5 molecules were established
using a pleiotropic retrovirus expression system and ana-
lyzed by flow cytometry. Measurable levels of both recep-
tors were expressed in the entire population of these cells
as indicated by the shift in their fluorescent intensity com-
pared to cells stained with a control antibody isotype (Fig.
1A–D). In addition a clone of CCRT cells expressing both
hCD4 and hCXCR4 (K4) was also established using
pCDNA3.1 expression vectors (Fig. 1E). The proportion of
double expressor cells in the population of this clone was
~32% during early passages and this proportion progres-
sively decreased with successive passages. Thus, an early
passage of this clone (passage #3) was used for the subse-
quent infection experiments. No increase in fluorescence
was detected when parental CCRT or VCRT cells were
stained with any of the anti co-receptors' antibodies (Fig.
1F and data not shown).Virology Journal 2009, 6:57 http://www.virologyj.com/content/6/1/57
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Cotton rat cells expressing human CD4 and HIV-1 co-
receptors are permissive for infection with HIV-1
To assess whether the expression of HIV-1 receptor com-
plex on cotton rat cells render them permissive for viral
infection, the different receptor expressing clones and the
parental cell lines were challenged with different HIV-1
isolates and the production of p24gag was measured in
supernatants after infection (Table 1). CCRT cells express-
ing hCD4 and hCXCR4 (K4 clone) were positive for the
production of p24gag after challenge with the MN (X4-
tropic) isolate, but produced only basal levels of p24gag
when challenged with the BAL (R5-tropic) isolate. On the
contrary, CCRT cells expressing hCD4 and hCCR5 (C6
clone) were positive for the production of p24gag when
infected with the R5-tropic isolates (BAL and US1), but
not when infected with the X4-tropic isolate MN. As
expected, parental CCRT cells only showed marginal lev-
els of production of p24gag after incubation with the dif-
ferent isolates.
To further examine whether the permissiveness of the cot-
ton rat for HIV-1 replication was not due to a unique char-
acteristic of the CCRT cell line, we engineered the cotton
rat VCRT cell line to express hCD4 and hCCR5, and chal-
lenged them with different HIV-1 isolates. As shown in
Table 1, the VCRT clone C17 showed significantly higher
levels of expression of p24gag (~1 ng) than those found in
the control parental VCRT line when infected with the
BAL isolate. These results demonstrate that cotton rat cells
expressing HIV-1 co-receptor complexes are permissive for
HIV-1 replication. Furthermore, since these clones were
originally derived from different cotton rat cell lines, these
data suggest that HIV-1 permissiveness of cotton rat cells
is not a cell type specific attribute.
Isolation and cloning of cotton rat cells expressing human co-receptors for HIV-1 Figure 1
Isolation and cloning of cotton rat cells expressing human co-receptors for HIV-1. (A), VCRT C17; (B), CCRT C4; 
(C), CCRT C5; (D), CCRT C6; and (E), CCRT K4, were established which expressed human CD4 molecule, with human 
CXCR4 or CCR5, as indicated. The expression of these surface molecules was measured by FACs using fluorescent antibodies 
against the indicated molecules (CD4, clone RPA-T4; CXCR4, clone 12G5; CCR5, clone 2D7) (filled profile) and compared to 
the staining obtained of the same cells with control antibody isotypes (empty profiles). (F) Staining profile of parental CCRT 
cells with the above mentioned antibodies, as indicated.Virology Journal 2009, 6:57 http://www.virologyj.com/content/6/1/57
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Kinetics of p24gag production by cotton rat transfectant 
cells after HIV-1 infection
Next, we infected the engineered cotton rat CD4 clones to
define the time course of p24gag production (Fig. 2).
When the CCRT K4 clone was infected with HIV-1 MN, a
peak in p24gag concentration was detected six days post-
infection, after which the amount of p24gag decreased
and subsequently was maintained at 2–4 ng/ml levels
until the last sample was taken on day 23 (Fig. 2A).
Infection of the CCRT clones (C4, C5 and C6) or the VCRT
clone C17, which express hCD4 and hCCR5, with the
HIV-1 BAL isolate showed similar results (Fig. 2B and 2C).
Some of the clones showed detectable levels of p24gag in
their supernatant as early as one day post infection (CCRT
C4, Fig. 2B; and VCRT C17, Fig. 2C), whereas the CCRT
C5 and C6 showed detectable p24gag expression starting
on day 4. Later than day 6 post-infection, the levels of
p24gag were reduced to about 50% of the peak level,
which paralleled the increase in cell mortality (data not
shown). Although the concentration of p24gag in the
supernatant of VCRT C17 infected cells was lower than
those obtained with the CCRT-derived clones, its concen-
tration was at all times higher than those obtained from
supernatants of the infected parental VCRT line. These
data further demonstrate that cotton rat cells expressing
the human receptor complex for HIV-1 become permis-
sive for HIV-1 infection and produce peak amounts of
p24gag in their supernatant 6 days post-challenge.
Detection of infectious virions in supernatants of HIV-1 
infected cotton rat cells
To demonstrate that the p24gag protein released into the
supernatants of infected cotton rat cells represented infec-
tious HIV-1 virus, supernatants obtained on day 6 post
challenge were used to infect HIV-1 permissive human
cells. p24gag positive supernatants from CCRT K4 cells
infected with MN virus (containing ~8 ng/ml of p24gag)
or from VCRT C17 cells infected with BAL virus (contain-
ing ~1 ng/ml of p24gag) were collected and used for infec-
tion of human PBMC and H9 cells (CCRT K4 derived
virus, Fig. 3A and 3B respectively) or only PBMC (VCRT
Table 1: p24gag Concentration (pg/ml) in Supernatantsa of 
Cotton Rat Cells infected with Different HIV-1 Isolates.
Cell Clonesb Virus Isolatesc
Mock BAL MN US1
CCRT <15 331 ± 20 110 ± 14 54 ± 2
CCRT K4 <15 33 ± 6 25095 ± 3191 n.d.d
CCRT C6 <15 18477 ± 1119 35 ± 2 16635 ± 1743
VCRT <15 142 ± 12 89 ± 9.5 46 ± 2
VCRT C17 <15 1072 ± 37 106 ± 8 40 ± 3
aSupernatants of each infection experiments were tested for the 
presence of p24gag in duplicates at several time post infection (day 1 
to 24) and the peak concentration is presented. Results represent 
means ± SD of at lease two experiments.
bCotton rat cell clones expressing human CD4 with CXCR4 (CCRT 
K4), or with CCR5 (CCRT C6 and VCRT C17).
cHIV-1 viral isolates X4-tropic (MN) and R5-tropic (BAL and US1).
d not determined.
Kinetic of the expression of p24gag in supernatants of cotton rat cell clones after HIV-1 infection Figure 2
Kinetic of the expression of p24gag in supernatants of cotton rat cell clones after HIV-1 infection. (A), CCRT 
parental cell line and the derived clone K4 which expresses hCD4 and hCXCR4 infected with MN isolate; (B), CCRT parental 
cell line and the C4, C5, and C6 derived clones expressing hCD4 and hCCR5 infected with HIV-1 BAL isolate; (C), VCRT 
parental cell line and the derived C17 clone expressing human CD4 and CCR5 infected with HIV-1 BAL isolate.Virology Journal 2009, 6:57 http://www.virologyj.com/content/6/1/57
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C17 derived virus, Fig. 3C). In some experiments, equiva-
lent amounts of p24gag protein (8 ng/ml) from stocks of
the strain MN prepared in H9 cells were tested as positive
control (Fig. 3A and 3B). Detectable amounts of p24gag
were obtained as early as day 6 post transfer of all the cot-
ton rat-derived stocks of virus (Fig. 3) but not when trans-
ferred stocks were prepared from mock inocula (data not
shown and Fig. 3C). A sharp increase in the production of
p24gag by the recipient human cells occurred on day 9
and continued increasing to reach a plateau when the
stocks used were derived from CCRT K4 cells infected with
MN (Fig. 4A and 4B).
A delay in the kinetics of expression of p24gag was
observed in stocks of HIV-1 derived from cotton rat cells
compared to H9-derived HIV-1 stocks (Fig. 3A and 3B).
This delay most likely represents lower p24gag:TCID50
ratios in the stocks prepared in the cotton rat and might
indicate that the virus passed through cotton rat cells
became less permissive to human cells. Overall, the com-
parable infectivities obtained with human and cotton rat
cell-derived virions demonstrate that fully mature, infec-
tious HIV-1 particles can be efficiently synthesized, assem-
bled and released from cotton rat cells.
Detection of episomal and integrated HIV-1 cDNA in 
infected cotton rat cells
In order to detect the presence of HIV-1 episomal cDNA
in infected cotton rat cells, total genomic DNA was iso-
lated from HIV-1 MN-infected or uninfected CCRT K4
cells and subjected to PCR amplification using primers
derived from the sequence of the LTRs of the HIV-1 MN
isolate. A unique fragment of the expected length (197
bp) and identity was found only in those DNA samples
obtained from infected cotton rat cells (Fig. 4A).
Finally, we examined whether the HIV-1 cDNA was able
to integrate into the genome of the infected cotton rat
cells. For this purpose, we analyzed total genomic DNA
from infected and uninfected cotton rat cells by PCR using
one primer that anneals to a known repetitive sequence in
the cotton rat genome (LINE-1 like sequence) and another
primer that anneals to the Long Terminal Repeats (LTRs)
sequence of the HIV-1 MN isolate. After amplification, the
resulting DNA products were separated by agarose gel
electrophoresis, and a fragment of ~1.6 Kbp detected only
in infected cells was isolated and cloned (Fig. 4B, arrow).
Sequencing revealed that this fragment had a chimeric
structure which included 650 bp of the 5' LTR of HIV-MN
and 950 bp of the cotton rat repetitive LINE-1 sequence
(GenBank accession no. AY703985), evidencing inser-
tions of viral cDNA into the genome of cotton rat cells.
These data clearly demonstrate that cotton rat cells are
able to support the integration of viral cDNA into their
genome.
Discussion
More than twenty five years following the first description
of AIDS and the subsequent isolation of HIV-1, there
remains a paucity of suitable small animal model systems
to study HIV-1 infection and pathogenesis. The absence of
the specific HIV-1 receptors on the cell membrane of these
small animal models has been a major obstacle for the
study of productive viral entry and infection. To circum-
vent this hurdle, mice expressing hCD4 and hCCR5 or
hCXCR4 were developed[10,11]. Preliminary results with
these mice were at first exciting because the expression of
the transgenes promoted viral entry, but these mice did
not support robust viral replication[11]. These results
were partly explained by differences between the human
and the mouse cyclin T1 (CycT1), which is an important
HIV-1 virus stocks produced in cotton rat cells infect human cells Figure 3
HIV-1 virus stocks produced in cotton rat cells infect human cells. Kinetic of p24gag expression by human PBMC (A), 
or by the human H9 T cell line (B), when infected with a stock of HIV-1 MN grown from CCRT K4 cells. The growth kinetic of 
the virus in these stocks is compared with the original MN stock grown on H9 cells. (C) Kinetics of P24gag expression by 
human PBMC infected with HIV-1 BAL isolate generated in the cotton rat cell line VCRT C17.Virology Journal 2009, 6:57 http://www.virologyj.com/content/6/1/57
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cellular component of the pTEFb transcription factor
complex responsible for transcription from the viral HIV-
LTR[20,21]. Thus, the humanized mouse models seem to
be the best alternative for HIV-1 pathogenesis studies
using this rodent[5,6]. In addition, transgenic rats (Rattus
norvegicus) expressing hCD4 and hCCR5 were devel-
oped[12]. Despite only transient HIV-1 replication in vivo,
this model was recently proposed as a system to allow
rapid clinical testing of antiviral compounds that target
virus entry or reverse transcription[15].
In our previous study[16], provirus was consistently
detected in PBMC preparations and other tissues (spleen,
thymus and bone marrow) from infected cotton rats. The
virus induced a strong, specific and long-lasting immune
response that was maintained up to 1 year post-infection.
Although not demonstrated by direct culture of PBMC or
tissues from infected animals, infectious virus replicated
at a low level in cotton rats since viral cDNA was detected
by PCR in animals that underwent three serial passages of
blood. In addition, Rytik and collaborators[19] detected
viral cDNA in spleen and brain of all the infected animals
6 months post-infection, showed increase in mortality
(17%), and found morphological changes in cells of the
CNS.
We have hypothesized that the expression of HIV-1 recep-
tors on the surface of cotton rat cells would allow them to
efficiently replicate HIV-1 virus. Different clones of cotton
rat cell lines expressing measurable levels of hCD4 and
hCCR5 or hCXCR4 were then produced and cultured with
infectious HIV-1. The data presented here clearly indicate
the productive infection of these cotton rat cells when
infected with well characterized HIV-1 strains (MN, BAL
and US1). Indicators of productive infection were [1]
p24gag detection in the supernatant of infected cells, [2]
detection of episomal viral cDNA in infected cells, [3]
demonstration of viral DNA integration into the genome
of the cells, and [4] production of infectious viral stocks in
cotton rat cells.
The amount of p24gag produced in the supernatants of
cotton rat cells infected with HIV-1 stocks was in the order
of the ng/ml and followed kinetics compatible with viral
production. In addition we showed that the expression of
the receptors on the cells determines the viral type specif-
icity. Thus, CCR5 expressing cells were only infected by
the R5-tropic strain BAL, whereas the CXCR4-expressing
clone was only susceptible to the X4-tropic strain MN
(Table 1).
We have readily detected viral episomal cDNA in HIV-1
infected cotton rat cells. However, it is the integration of
the retroviral cDNA into the host chromosomal DNA that
is the essential and distinctive step in viral replication. It
has been shown that HIV-1 is able to integrate near repet-
itive sequences of the genome[22,23]. Although these are
not the most favorable sites for integration[24], the inser-
tion in their vicinity occurs most likely due to the abun-
dance of these sequences in the genome (LINE 1 repetitive
sequences are ~13% of the human genome). To demon-
strate viral cDNA integration in cotton rat cells, we per-
formed PCR reactions using a primer that annealed the
LTR sequence of HIV-1 MN strain and a primer that
annealed a repetitive LINE-1 like sequence in the cotton
rat genome. With this set of primers we were able to iso-
late, clone, and sequence a fragment from infected cells
that was a chimera between the LTRs sequence of HIV-1
and a LINE-1 repetitive sequence of the cotton rat [Gen-
Bank accession no. AY703985]. These data clearly demon-
strate that the cotton rat cells, upon infection, are able to
integrate HIV cDNA and use it as a template for replica-
tion.
Generation of HIV-1 viral stocks using clones of cotton rat
cells expressing the human HIV-1 receptor complex was
the final demonstration of productive replication in these
cells. These stocks of virus infected human cells to similar
extents as those stocks of virus produced in human cells,
although with slight delay in the kinetics of p24gag pro-
duction. This delay most likely represents a lower ratio of
p24:infectivity and could suggest a less efficient assembly
of progeny virions in cotton rat cells or the fact that the
virus suffered some adaptations to the cotton rat system
that rendered it less efficient in the subsequent infection
of human cells.
Detection of episomal cDNA and isolation of cotton rat- HIV-1 chimeric DNA sequence from HIV-1 infected cotton  rat cells Figure 4
Detection of episomal cDNA and isolation of cotton 
rat-HIV-1 chimeric DNA sequence from HIV-1 
infected cotton rat cells. (A), CCRT K4 cotton rat clone 
infected with HIV-1 MN and incubated for 4 days before iso-
lation of genomic DNA for the detection of episomal cDNA. 
Numbers on the top represent the amounts of DNA (ng) 
used as input for each PCR reaction. HIV and β-actin panels 
indicate the fragments amplified in each panel. (B), DNA 
preparations from infected (HIV) and uninfected (mock) 
CCRT K4 cells were subjected to PCR amplification using 
one primer targeting a genomic cotton rat sequence and 
another primer targeting the sequence of HIV-1 MN LTR. 
The indicated band (arrow) was isolated, cloned and its 
sequence (GenBank AY703985) confirmed the integration of 
HIV-1 into the cotton rat genome.Virology Journal 2009, 6:57 http://www.virologyj.com/content/6/1/57
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There is currently a great effort focused on the develop-
ment of microbicides to prevent sexually transmitted dis-
eases (STDs). Epidemiological studies consistently
demonstrated that recurrent infection by herpes simplex
virus (HSV) increases the risk of HIV-1 acquisition and
enhances HIV-1 replication[25,26]. PRO 2000, a synthetic
naphthalene sulfonic polymer, interacts with viral glyco-
proteins gp120 of HIV and glycoprotein B of HSV-2 and
has been tested as microbicide to prevent viral infection.
PRO 2000 gel has been shown to inhibit vaginal simian/
human immunodeficiency virus infection in
macaques[27], HSV-2 infection in mice[28], gonorrhea in
mice[29]. In recent clinical trials sponsored by NIAID
(The HPTN 035 Study of Two Candidate Microbicides,
BufferGel and PRO 2000 (0.5% dose)), PRO2000 was
30% more efficient than the placebo treatment to reduce
HIV infection. We have previously developed a cotton rat
model of vaginal HSV-2 infection[30]. Importantly, intra-
vaginal pretreatment of PRO 2000 fully protected cotton
rats against the challenge with HSV-2. These data indicate
that microbicides active against STDs have been success-
fully tested in the cotton rat model.
Conclusion
We have demonstrated that expression of HIV-1 receptors
on the surface of cotton rat cells allows full cycle replica-
tion of the virus and further supports the potential of the
cotton rat as a small animal model for the study of HIV-1
disease and pathogenesis. Efforts are currently being
directed to the production of transgenic cotton rats (Sig-
modon sp.) expressing human CD4, chemokine receptors,
and human Cyclin T1 gene, on macrophages, microglia
and T cells. Since this model has shown some low permis-
sibility to HIV in the past, it will be important to deter-
mine how the expression of the human receptors in vivo
will correlate with the data presented here.
Methods
Cells and culture conditions
The cotton rat cell lines CCRT (an osteogenic sarcoma)
and VCRT (an undifferentiated spindle cell sarcoma) were
isolated from inbred S. hispidus spontaneous tumors and
they are routinely used in our laboratory[31]. Cells were
cultured in Dulbecco Minimal Essential Media (D-MEM)
with addition of 10% Fetal Calf Serum (FCS), 2 mM L-
glutamine, 100 U/ml of penicillin, and 100 μg/ml of
streptomycin. Cells were passed twice weekly and cultured
at 37°C in a humidified atmosphere of 5% CO2.
HIV-1 viral isolates
All virus isolates were from clade B of HIV-1[32] and were
tissue culture adapted. The MN isolate was prepared and
titrated in the human T lymphocyte cell line H9. The BAL
and US1 isolates were prepared in the CCR5-transfected
human acute lymphoblastic leukemia cell line A3/R5 and
titrated in PHA-activated, CD8-depleted PBMC (human
PBMC from an HIV-1 negative donor).
Isolation of cotton rat cells expressing human CD4 and 
HIV-1 co-receptors
A clone of CCRT cells expressing hCD4 and hCXCR4
receptors (clone K4), was established by plasmid transfec-
tion. Briefly, the day before transfection parental CCRT
cells were seeded into a 6-well plate at a density of 3 × 105
cell/well. The next day, the cells were transfected with a
mixture containing the pCDNA3.1 expression vector for
human CD4 (2 μg), and 6 μl of transfection reagent
(FuGENE 6, Roche Molecular Biochemical). Stably trans-
fected cells were selected by incubating the cultures in
complete media with 800 μg/ml of geneticin (G418, Inv-
itrogen). Small foci of resistant cells were subjected to pos-
itive selection using an anti-human CD4 antibody
(monoclonal antibody RPA-T4, BD) and Dynabeads®
M450 conjugated with goat anti-mouse IgG (Dynal cat#
110.05). Subsequently, this pool of CCRT cells expressing
hCD4 (4 × 106 cells) was electroporated with a mixture
containing the pCDNA3.1 expression vector for hCXCR4
(10 μg), a selection plasmid (pGK-HygroB, 4 μg), and a
carrier plasmid (pGEM-7zf +, 6 μg). Double transfected
cells were selected in complete D-MEM media containing
800 μg/ml of G-418 and 500 μg/ml of hygromycin B and
screened in situ for the expression of hCXCR4 with an
anti-hCXCR4 monoclonal antibody (clone 12G5, IgG2a,
κ, BD cat# 555974) and magnetic beads. Due to low levels
of hCD4 expression in the CCRT K4 clone, most likely due
to the silencing effect of chromatin on the integrated pro-
moter, we enhanced the expression of the receptors by
incubating the cell with the chromatin relaxing agent tri-
chostatin A (TSA, 100 ng/ml)[33].
CCRT and VCRT cells stably expressing hCD4 and hCCR5
receptors were produced by transduction of both cell lines
with infectious, replication-incompetent, retroviral parti-
cles encoding hCD4 and hCCR5 genes under the human
cytomegalovirus immediate early promoter (pLCNX2 ret-
roviral vector). Transduced cells were selected using G418
(800 μg/ml) and puromycin (300 μg/ml) and resistant
clones were screened in situ for the expression of hCD4
and hCCR5 by antibody-conjugated to magnetic beads
(hCD4, RPA-T4; anti-hCCR5, monoclonal antibody clone
2D7, IgG2a, κBD cat# 555993). Positive clones were fur-
ther amplified and frozen.
Infection of cotton rat cells
Filtered stocks (0.2 μM filter) of different HIV-1 isolates
were used in all experiments. Cells were seeded in 24-well
or 6-well plates at densities of 4 × 104 and 8 × 104 cells/
well respectively, and allowed to attach for 24 h. In the
case of the CCRT K4 clone, cells were induced with 100
ng/ml of TSA for additional 16 h[33] before infection.Virology Journal 2009, 6:57 http://www.virologyj.com/content/6/1/57
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Stocks of the different isolates of HIV-1 (~1 and 2 × 104
TCID50) were added to each well and incubated for 4 h at
37°C. After infection, the cultures were washed several
times with PBS, and cultured in fresh complete D-MEM
overnight. Samples of supernatants were obtained at dif-
ferent times after infection and tested for the concentra-
tion of extracellular p24gag using a commercially
available kit (p24 antigen assay kit from Coulter Immu-
nology, cat# 6607051). For viral infectivity, PHA-acti-
vated, CD8-depleted PBMC or H9 cells were used as the
recipient cells, and they were seeded at a density of 106
cells/well in a 24-well plate.
Detection of HIV-1 cDNA and detection of integrated HIV-
1 genome
CCRT K4 cells were seeded at a density of 8 × 104 cells per
well of a six well plate, cultured for 24 h and induced with
100 ng/ml of TSA for an additional 16 h. The next day
cells were infected with HIV-1 MN virus (1.6 × 104
TCID50) or with a mock viral preparation. Cells were incu-
bated with the inocula for 4 h, washed with PBS, and incu-
bated with fresh media for three additional days before
using the monolayer for genomic DNA isolation using a
Qiagen DNA isolation kit (Cat# 69504). Detection of
HIV-1 cDNA was performed by PCR amplification using
the following primers: (forward, 5' GGCTAACTAG-
GGAACCCACTGCTT 3'; reverse, 5' CCGAGTCCTGCGTC-
GAGAGAGC 3') and conditions (35 cycles with annealing
temperature of 59°C). Equivalent dilutions of genomic
DNA from CCRT K4 infected and mock-infected cell were
used as input DNA in the PCR reactions. β-actin gene
amplification was used as internal control and primers
were previously described[34]. The expected products
were confirmed by sequencing.
For detection of integrated HIV-1 genomes in cotton rat
infected cells, a PCR reaction was designed using one
primer targeting the Long Terminal Repeat (LTR)
sequence of HIV-1 MN isolate (GenBank accession no.
AF075719, 5' CTGTTCGGGCGCCACTGCTAGAG 3') and
another targeting a repetitive DNA sequence in the cotton
rat genome (LINE-1 retroposon ORF II pseudogene, Gen-
Bank accession no. AY041614, 5' AAAGAACAATACT-
CAATTTCATTTGG 3') using as reaction conditions 58°C
for annealing and 2 minutes for extension time during 35
cycles.
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